From the Comagine Health, Portland, OR (ES, SS, KL, JP, GL); Department of Medicine, Section of Addiction Medicine, Oregon Health & Science University, Portland, OR (JEL, DH, PTK); HIV Alliance, Eugene, OR (MB); Oregon Health Authority, Acute and Communicable Disease Prevention, Public Health Division, Oregon Health Authority, Portland, OR (JML); Oregon Health Authority, Injury and Violence Prevention Program, Public Health Division, Oregon Health Authority, Portland, OR (LC); and Oregon Health & Science University-Portland State University School of Public Health, Portland, OR (PTK).
J Addict Med. 2022;16(6):695-701. doi: 10.1097/ADM.0000000000001002. Epub 2022 Jul 8.
The objective of this study was to examine COVID-19 vaccination acceptance and explore reasons for COVID-19 vaccine hesitancy among people who use drugs (PWUDs), a population with increased COVID-19 transmission and morbidity.
We conducted semi-structured in-depth interviews with PWUDs in 7 Oregon counties from May 11 to June 25, 2021. Participants (n = 34) were recruited in partnership with syringe service programs and local community organizations staff, participant-referrals, and flyer advertising. Research staff conducted interviews via telephone to assess participants' acceptance of the COVID-19 vaccine, find knowledge gaps where new educational information about vaccination would be helpful, and identify who would be perceived as a trustworthy source of information. Interviews were transcribed and coded using thematic analysis with a deductive approach.
Most participants had not received the COVID-19 vaccine and were not planning on or were unsure about receiving it. Participants were mistrustful of the rapid COVID-19 vaccine development process, the agencies involved in the development, and vaccines in general. Participants shared varied and contrasting responses about who they would trust to provide information about the COVID-19 vaccine, including peer recovery support specialists, doctors, or other health care professionals, and specified federal agencies or media outlets.
As addiction medicine and public health staff continue to respond to the evolving impacts of COVID-19, vaccination planning should be tailored to the unique needs of PWUD to increase COVID-19 vaccine acceptance in this high-risk population.
本研究旨在调查吸毒人群（PWUD）对 COVID-19 疫苗的接受程度，并探讨其对 COVID-19 疫苗的犹豫原因，这些人群具有更高的 COVID-19 传播和发病风险。
我们于 2021 年 5 月 11 日至 6 月 25 日在俄勒冈州的 7 个县对吸毒人群进行了半结构式深入访谈。研究人员与注射器服务项目和当地社区组织工作人员合作，通过参与者推荐和传单广告招募参与者。研究人员通过电话进行访谈，评估参与者对 COVID-19 疫苗的接受程度，找出对疫苗接种有新的教育信息需求的知识空白，并确定谁被认为是可信的信息来源。访谈记录进行了转录，并采用归纳法进行主题分析。
大多数参与者尚未接种 COVID-19 疫苗，且不打算或不确定接种。参与者对 COVID-19 疫苗的快速开发过程、参与开发的机构以及疫苗总体持不信任态度。参与者对谁会信任来提供 COVID-19 疫苗信息的问题有不同的、相互矛盾的反应，包括同伴康复支持专家、医生或其他医疗保健专业人员，以及指定的联邦机构或媒体。
随着成瘾医学和公共卫生工作人员继续应对 COVID-19 的不断变化的影响，应根据吸毒人群的独特需求制定疫苗接种计划，以提高该高风险人群对 COVID-19 疫苗的接受程度。
